SOTIO Biotech

Sotio Biotech

Biotechnology, 180 Canal St, Prague, Massachusetts, 02114, United States, 201-500 Employees

sotio.com

  • twitter
  • LinkedIn

Who is SOTIO BIOTECH

SOTIO Biotech is shaping the future of cancer immunotherapies by translating compelling science into patient benefit. SOTIOs robust clinical pipeline includes a next-generation PD-1-inhib...

Read More

map
  • 180 Canal St, Prague, Massachusetts, 02114, United States Headquarters: 180 Canal St, Prague, Massachusetts, 02114, United States
  • 2010 Date Founded: 2010
  • 201-500 Employees: 201-500
  • dollar-icon Revenue: $25 Million to $50 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 8069 | NAICS Code: 541715 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from SOTIO BIOTECH

SOTIO Biotech Org Chart and Mapping

Employees

Tanja Smith

Lead Supply Chain and Logistics Coordinator

Shalimar Hachem

Senior Associate Scientist

Lorraine Whittemore

Regulatory Affairs and Quality Assurance, Vice President

Barbara Dula

Quality Assurance Manager

Robyn Hunter

Chief Financial Officer

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding SOTIO Biotech

Answer: SOTIO Biotech's headquarters are located at 180 Canal St, Prague, Massachusetts, 02114, United States

Answer: SOTIO Biotech's official website is https://sotio.com

Answer: SOTIO Biotech's revenue is $25 Million to $50 Million

Answer: SOTIO Biotech's SIC: 8069

Answer: SOTIO Biotech's NAICS: 541715

Answer: SOTIO Biotech has 201-500 employees

Answer: SOTIO Biotech is in Biotechnology

Answer: SOTIO Biotech contact info: Phone number: Website: https://sotio.com

Answer: SOTIO Biotech is shaping the future of cancer immunotherapies by translating compelling science into patient benefit. SOTIOs robust clinical pipeline includes a next-generation PD-1-inhibiting cytokine, a proprietary technology designed to improve on the efficacy of CAR T therapies and a new generation of potent and stable antibody-drug conjugates (ADCs). SOTIO is a member of the PPF Group.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access